Insider Transactions in Q3 2020 at Horizon Therapeutics Public LTD CO (HZNP)
Insider Transaction List (Q3 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 17
2020
|
Irina Konstantinovsky EVP, Chief Human Resources Off |
BUY
Exercise of conversion of derivative security
|
Direct |
21,351
+27.12%
|
$298,914
$14.05 P/Share
|
|
Sep 16
2020
|
Irina Konstantinovsky EVP, Chief Human Resources Off |
SELL
Open market or private sale
|
Direct |
8,919
-19.85%
|
$695,682
$78.88 P/Share
|
|
Sep 11
2020
|
Irina Konstantinovsky EVP, Chief Human Resources Off |
SELL
Payment of exercise price or tax liability
|
Direct |
7,095
-13.63%
|
$496,650
$70.54 P/Share
|
|
Sep 11
2020
|
Irina Konstantinovsky EVP, Chief Human Resources Off |
BUY
Grant, award, or other acquisition
|
Direct |
16,014
+23.53%
|
-
|
|
Sep 04
2020
|
Brian K Beeler EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
28,143
+20.0%
|
$394,002
$14.88 P/Share
|
|
Aug 24
2020
|
Paul W. Hoelscher EVP, CFO |
SELL
Open market or private sale
|
Indirect |
29,576
-11.34%
|
$2,218,200
$75.98 P/Share
|
|
Aug 06
2020
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
110,000
-2.29%
|
$8,030,000
$73.31 P/Share
|
|
Aug 05
2020
|
Michael G Grey Director |
SELL
Open market or private sale
|
Direct |
1,755
-100.0%
|
$128,115
$73.35 P/Share
|
|
Aug 05
2020
|
Michael G Grey Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,755
+50.0%
|
$5,265
$3.95 P/Share
|
|
Aug 03
2020
|
Vikram Karnani EVP & President, International |
BUY
Exercise of conversion of derivative security
|
Direct |
36,772
+19.91%
|
$551,580
$15.68 P/Share
|
|
Aug 03
2020
|
Gino Santini Director |
BUY
Exercise of conversion of derivative security
|
Direct |
35,795
+36.95%
|
$107,385
$3.22 P/Share
|
|
Aug 02
2020
|
Pascale Witz Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
3,221
-8.51%
|
$196,481
$61.19 P/Share
|
|
Aug 02
2020
|
Pascale Witz Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
8,204
+17.82%
|
-
|
|
Aug 02
2020
|
James Samuel Shannon Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
3,221
-8.75%
|
$196,481
$61.19 P/Share
|
|
Aug 02
2020
|
James Samuel Shannon Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
8,204
+18.22%
|
-
|
|
Jul 22
2020
|
Michael G Grey Director |
SELL
Open market or private sale
|
Direct |
1,755
-100.0%
|
$105,300
$60.0 P/Share
|
|
Jul 22
2020
|
Michael G Grey Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,755
+50.0%
|
$5,265
$3.95 P/Share
|
|
Jul 07
2020
|
Barry Moze EVP, Chief Admin. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
35,076
+6.51%
|
$491,064
$14.15 P/Share
|
|
Jul 07
2020
|
Jeff Kent Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,000
+17.59%
|
$190,000
$5.78 P/Share
|
|
Jul 06
2020
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
9,100
-3.16%
|
$518,700
$57.5 P/Share
|
|
Jul 01
2020
|
Barry Moze EVP, Chief Admin. Officer |
SELL
Open market or private sale
|
Direct |
23,158
-7.06%
|
$1,273,690
$55.02 P/Share
|